Reldesemtiv (CK-2127107) is a selective fast skeletal muscle troponin activator with an EC50 of 3.4 µM. It has been investigated in preclinical models for conditions involving muscle weakness, such as heart failure, where it has shown potential to improve exercise performance in vivo.